Allakos Inc. (ALLK)
Pharmaceutical Preparations
Insiders
| Type of Owner | Securities Owned | As Insider in other Companies | Date Last Transaction | ||
|---|---|---|---|---|---|
| 10%own | 22,788,400 | 1 | 2018-07-23 | ||
| Dir | 9,050,493 | 5 | 2022-09-21 | ||
| 10%own | 8,519,200 | 0 | 2021-01-04 | ||
| 10%own | 6,448,053 | 2 | 2021-03-04 | ||
| 10%own | 4,610,723 | 3 | 2018-07-23 | ||
| member - potential 10% group | 2,079,147 | 0 | 2021-03-09 | ||
| member - potential 10% group | 2,071,147 | 2 | 2021-03-03 | ||
| Chief Medical Officer | 323,472 | 0 | 2023-12-04 | ||
| Chief Medical Officer | 275,046 | 0 | 2024-12-04 | ||
| CLO, GC, Secretary | 226,935 | 0 | 2022-03-02 | ||
| Secretary, General Counsel | 153,128 | 1 | 2022-09-02 | ||
| Chief Medical Officer | 100,985 | 0 | 2021-06-03 | ||
| CFO | 51,958 | 0 | 2020-12-01 | ||
| Dir, CEO | 0 | 0 | 2025-05-15 | ||
| 10%own | 0 | 14 | 2025-05-15 | ||
| Dir | 0 | 1 | 2023-08-15 | ||
| Dir | 0 | 0 | 2021-09-28 | ||
| Dir | 0 | 1 | 2022-07-11 | ||
| Dir | 0 | 0 | 2021-03-26 | ||
| CFO | 0 | 0 | 2025-05-15 | ||
| Dir | 0 | 2 | 2023-07-21 | ||
| Dir | 0 | 1 | 2023-07-21 | ||
| President | 0 | 0 | 2025-05-15 | ||
| Dir | 0 | 9 | 2025-05-15 |
*: Insider is not longer subject to Section 16
Securities owned over time
Recent trades
| Transaction Date | Insider | Title | Form | Trade Types | Δ Securities | Δ Cash | Owned | |
|---|---|---|---|---|---|---|---|---|
| 2025-05-15 | Tomasi Adam | President | 4 | D | −533,420 | $0 | 0 | |
| 2025-05-15 | Radford Harlan Baird | CFO | 4 | D | −163,426 | $0 | 0 | |
| 2025-05-15 | Alexander Robert | Dir, CEO | 4 | D | −1,058,404 | $0 | 0 | |
| 2025-05-15 | Walker Paul Edward | Dir | 4 | D | −6,147,260 | $0 | 0 | |
| 2025-05-15 | Bvf Partners L P/il | 10%own | 4 | D | −16,312,872 | $0 | 0 | |
| 2025-03-06 | Alexander Robert | Dir, CEO | 4 | F | −31,370 | $0 | 1.06M | |
| 2025-03-05 | Tomasi Adam | President | 4 | F | −20,017 | $0 | 533.42K | |
| 2025-03-05 | Radford Harlan Baird | CFO | 4 | F | −14,161 | $0 | 163.43K | |
| 2024-12-06 | Tomasi Adam | President | 4 | F | −21,116 | $0 | 553.44K | |
| 2024-12-06 | Radford Harlan Baird | CFO | 4 | F | −13,138 | $0 | 177.59K | |
| 2024-12-05 | Alexander Robert | Dir, CEO | 4 | F | −32,466 | $0 | 1.09M | |
| 2024-12-04 | Lee Chin Hyok | Chief Medical Officer | 4 | F | −10,634 | $0 | 275.05K | |
| 2024-09-11 | Alexander Robert | Dir, CEO | 4 | F | −37,311 | $0 | 1.12M | |
| 2024-09-09 | Lee Chin Hyok | Chief Medical Officer | 4 | F | −45,320 | $0 | 285.68K | |
| 2024-09-06 | Tomasi Adam | President | 4 | F | −21,961 | $0 | 574.55K | |
| 2024-09-06 | Radford Harlan Baird | CFO | 4 | F | −13,665 | $0 | 190.73K | |
| 2024-06-28 | Radford Harlan Baird | CFO | 4 | S | −87,064 | $87.9K | 204.39K | |
| 2024-06-07 | Tomasi Adam | President | 4 | F | −24,749 | $0 | 593.51K | |
| 2024-06-06 | Alexander Robert | Dir, CEO | 4 | F | −37,525 | $0 | 1.16M | |
| 2024-06-04 | Radford Harlan Baird | CFO | 4 | F | −14,565 | $0 | 291.45K |